Skip to main content
TipRanks
Go Ultimate75% OFF

LeonaBio (LONA) Stock Statistics & Valuation Metrics

578 Followers

Total Valuation

LeonaBio has a market cap or net worth of $36.09M. The enterprise value is $52.90M.

Market Cap
$36.09M
Enterprise Value
$52.90M

Share Statistics

LeonaBio has 13,076,348 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
13,076,348
Owned by Insiders
65.23%
Owned by Institutions
9.92%

Financial Efficiency

LeonaBio’s return on equity (ROE) is -3.80 and return on invested capital (ROIC) is -226.69%.

Return on Equity (ROE)
-3.80
Return on Assets (ROA)
-1.15
Return on Invested Capital (ROIC)
-226.69%
Return on Capital Employed (ROCE)
-2.29
Revenue Per Employee
0
Profits Per Employee
-5.56M
Employee Count
19
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of LeonaBio is -0.09. LeonaBio’s PEG ratio is 0.00.

PE Ratio
-0.09
PS Ratio
0.00
PB Ratio
4.45
Price to FCF
-0.16
Price to Operating Cash Flow
-0.94
PEG Ratio
0.00

Income Statement

In the last 12 months, LeonaBio had revenue of 0 and earned -105.61M in profits. Earnings per share was -24.70.

Revenue
0
Gross Profit
-68.09M
Operating Income
-102.27M
Pretax Income
-105.61M
Net Income
-105.61M
EBITDA
-33.21M
Earnings Per Share (EPS)
-24.70

Cash Flow

In the last 12 months, operating cash flow was -61.93M and capital expenditures 0, giving a free cash flow of -61.93M billion.

Operating Cash Flow
-61.93M
Free Cash Flow
-61.93M
Free Cash Flow per Share
-3.21

Dividends & Yields

LeonaBio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-672.81%
Earnings Yield
-228.97%

Stock Price Statistics

Beta
1.22
52-Week Price Change
-40.00%
50-Day Moving Average
5.34
200-Day Moving Average
7.50
Relative Strength Index (RSI)
26.06
Average Volume (3m)
193.22K

Important Dates

LeonaBio upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

LeonaBio as a current ratio of 1.88, with Debt / Equity ratio of 2.89%

Current Ratio
1.88
Quick Ratio
1.88
Debt to Market Cap
0.01
Net Debt to EBITDA
2.06
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, LeonaBio has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

LeonaBio EV to EBITDA ratio is 0.07, with an EV/FCF ratio of 0.06.

EV to Sales
0.00
EV to EBITDA
0.07
EV to Free Cash Flow
0.06
EV to Operating Cash Flow
0.06

Balance Sheet

LeonaBio has $51.07M in cash and marketable securities with $577.00K in debt, giving a net cash position of $50.49M billion.

Cash & Marketable Securities
$51.07M
Total Debt
$577.00K
Net Cash
$50.49M
Net Cash Per Share
$3.86
Tangible Book Value Per Share
$7.86

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for LeonaBio is $16.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$16.33
Price Target Upside
491.79% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
―
EPS Growth Forecast
-131.18%

Scores

Smart Score
2
AI Score
45